Glioblastoma immunotherapeutic SurVaxM studied at Norton Healthcare Brain Tumor Center
Researchers at the Norton Healthcare Brain Tumor Center are conducting a clinical trial to determine whether a promising new immunotherapy drug, SurVaxM, improves survivability of glioblastoma. SurVaxM targets survivin, a protein in 95% of glioblastomas [...]
View more
Case study: Awake brain tumor resection helps preserve healthy tissue
The patient A 39-year-old nursing student initially presented with complaints of a two-year history of intermittent numbness in the tips of the middle and ring finger on her left hand. Over the past six months, […]
View more
Cushing’s or ACTH-secreting pituitary adenoma?
The patient A 48-year-old woman presented with a history of morbid obesity (376 pounds, BMI 66 kg/m²), hypertension (142/80 on multiple antihypertensive medications), uncontrolled diabetes mellitus (hemoglobin A1C of 9.1), worsening fatigue and increasing facial […]
View more
New use for tumor treatment fields device showing results for glioblastoma patients
After participating in a groundbreaking clinical trial that showed the Optune tumor treatment field device improves glioblastoma multiforme survival when combined with chemotherapy, neuro-oncologists at the Norton Healthcare Brain Tumor Center in Louisville, Kentucky, are […]
View more
Brain tumor study: Using Gleolan fluorescent marker to reveal diffusely infiltrative glioma tumor
The patient A 57-year-old man presented to the Norton Brownsboro Hospital emergency department with complaints of headaches that started two weeks earlier and worsened over the preceding few days. In addition, his family reported subtle […]
View more